finance.senate.gov

high credibility

Source scorecard — credibility, citation history, and editorial transparency for this domain.

3

Citations

3

High credibility

0

Medium credibility

2

Theory pages

Cited-theory verdict breakdown

Confirmed

2

Theory coverage

GSK Avandia CV risk concealment (1999–2010)Vioxx cardiovascular concealment (Merck, 1999-2004)

high credibilityUS Senate Finance Committee2010

Senate Finance Committee: GSK and Avandia safety data

Senators Baucus and Grassley

Open source Cited by GSK Avandia CV risk concealment (1999–2010)

high credibilityUS Senate Finance Committee2005

Internal Merck Vioxx documents: Senate Finance Committee

Senate Finance Committee

Open source Cited by Vioxx cardiovascular concealment (Merck, 1999-2004)

high credibilityU.S. Senate Finance Committee2010

Rosiglitazone and Cardiovascular Risk — Senate Finance Committee Report

Senators Baucus and Grassley

Open source Cited by GSK Avandia CV risk concealment (1999–2010)

Browse all source domains